UOC
IFRX icon

UBS O'Connor’s InflaRx IFRX Stock Holding History

UBS O'Connor’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-150,000
Closed -$119K – 356
2025
Q2 		$119K Buy
150,000
+91,927
+158% +$109K ﹤0.01% 314
2025
Q1 		$59.2K Sell
58,073
-567,516
-91% -$1.07M ﹤0.01% 279
2024
Q4 		$1.55M Sell
625,589
-172,287
-22% -$331K 0.04% 185
2024
Q3 		$1.22M Buy
797,876
+76,108
+11% +$116K 0.03% 255
2024
Q2 		$1.26M Buy
721,768
+339,359
+89% +$498K 0.04% 267
2024
Q1 		$589K Buy
382,409
+180,529
+89% +$295K 0.02% 320
2023
Q4 		$329K Sell
201,880
-188,120
-48% -$322K 0.01% 384
2023
Q3 		$1.16M Buy
390,000
+85,000
+28% +$324K 0.02% 313
2023
Q2 		$1.36M Buy
+305,000
New +$1.37M 0.03% 349

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

UBS O'Connor's IFRX Position: Q3 2025 in Review

UBS O'Connor sold out of InflaRx (IFRX) in Q3 2025, closing a stake of 150,000 shares — an estimated $119K sold.

UBS O'Connor first reported a position in IFRX in Q2 2023 and held it in 9 quarters. The position peaked at $1.55M in Q4 2024. 27 funds tracked by Wall St. Rank hold IFRX as of Q3 2025.

  • UBS O'Connor reported no remaining InflaRx position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 150,000 InflaRx shares in Q3 2025, an estimated $119K.
  • UBS O'Connor first reported a position in InflaRx in Q2 2023 and held it in 9 quarters.
  • UBS O'Connor's InflaRx position peaked at $1.55M in Q4 2024.
  • 27 funds tracked by Wall St. Rank held InflaRx as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.